Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
Clinical trial NCT00126191 · TERMINATED
Trial details
- NCT number
- NCT00126191
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2009-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.